Global analysis of DNA methylation in early-stage liver fibrosis

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Komatsu, Yoko ^a   Waku, Tsuyoshi ^a   Iwasaki, Naoya ^a   Ono, Wakana ^a   Yamaguchi, Chie ^a   Yanagisawa, Junn ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SECRETED PHOSPHOPROTEIN 1 GENE; ANIMAL; BIOLOGY; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHROMOSOME; GENETIC EPIGENESIS; GENETICS; GENOMICS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; REPRODUCIBILITY; TIME;

CARBON TETRACHLORIDE; DNA BINDING PROTEIN; OSTEOPONTIN; SPP1 PROTEIN, HUMAN;

ANIMALS; CARBON TETRACHLORIDE; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, MAMMALIAN; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE ANNOTATION; OSTEOPONTIN; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84856204784     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-5     Document Type: Article

References (40)

1. Liver fibrosis. Bataller R, Brenner DA, The Journal of clinical investigation 2005 115 2 209 218 15690074 (Pubitemid 40385459)
2. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. Iredale JP, The Journal of clinical investigation 2007 117 3 539 548 10.1172/JCI30542 17332881 (Pubitemid 46348508)
3. Updated treatment approach to hepatocellular carcinoma. Llovet JM, Journal of gastroenterology 2005 40 3 225 235 10.1007/s00535-005-1566-3 15830281 (Pubitemid 40613379)
4. Liver fibrosis - from bench to bedside. Friedman SL, Journal of hepatology 2003 38 Suppl 1 38 53 12591185
5. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Friedman SL, Nature clinical practice 2004 1 2 98 105 10.1038/ncpgasthep0055 16265071 (Pubitemid 40823677)
6. Mechanism of Hepatic Fibrogenesis. Friedman SL, Gastroenterology 2008 134 1655 1669 10.1053/j.gastro.2008.03.003 18471545 (Pubitemid 351615417)
7. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Mann J, Oakley F, Akiboye F, Elsharkawy A, Thorne AW, Mann DA, Cell death and differentiation 2007 14 2 275 285 10.1038/sj.cdd.4401979 16763620 (Pubitemid 46092230)
8. Methylation determines fibroblast activation and fibrogenesis in the kidney. Bechtel W, McGoohan S, Zeisberg EM, Muller GA, Kalbacher H, Salant DJ, Muller CA, Kalluri R, Zeisberg M, Nature medicine 2010 16 5 544 550 10.1038/nm.2135 20418885
9. Unravelling fibrosis: two newcomers and an old foe. Ortiz A, Ucero AC, Egido J, Nephrol Dial Transplant 2010 25 11 3492 3495 10.1093/ndt/gfq518 20833689
10. The human genome browser at UCSC. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D, Genome research 2002 12 6 996 1006 12045153 (Pubitemid 34662293)
11. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, et al. Molecular medicine (Cambridge, Mass 2009 15 3-4 85 94
12. Gene expression patterns in human liver cancers. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al. Molecular biology of the cell 2002 13 6 1929 1939 10.1091/mbc.02-02-0023. 12058060 (Pubitemid 34651483)
13. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et al. Hepatology (Baltimore, Md 2007 45 4 938 947 10.1002/hep.21622 (Pubitemid 46646500)
14. ONCOMINE: a cancer microarray database and integrated data-mining platform. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM, Neoplasia (New York, NY 2004 6 1 1 6 (Pubitemid 38391943)
15. Epigenetic control of rDNA loci in response to intracellular energy status. Murayama A, Ohmori K, Fujimura A, Minami H, Yasuzawa-Tanaka K, Kuroda T, Oie S, Daitoku H, Okuwaki M, Nagata K, et al. Cell 2008 133 4 627 639 10.1016/j.cell.2008.03.030 18485871 (Pubitemid 351636301)
16. Mexican infants with extrahepatic biliary atresia display different fibrosis activity. Fabre Y, Bueno MR, Rincon-Sanchez AR, Saldana-Cortes J, Vargas R, Armendariz-Borumda J, Hepatology Research 2004 28 79 86 10.1016/j.hepres.2003.10.004 (Pubitemid 38181626)
17. Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Jiang L, Gonda TA, Gamble MV, Salas M, Seshan V, Tu S, Twaddell WS, Hegyi P, Lazar G, Steele I, et al. Cancer research 2008 68 23 9900 9908 10.1158/0008-5472.CAN-08-1319 19047171
18. Hepatic fibrosis as wound repair: a progress report. Bissell DM, Journal of gastroenterology 1998 33 2 295 302 10.1007/s005350050087 9605966 (Pubitemid 28143414)
19. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Gallinari Paola, Stefania Di Marco, Jones Phillip, Pallaro Michele, Christian Steinkühler, Cell Research 2007 17 195 211 17325692 (Pubitemid 46438722)
20. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. Nature 2009 459 7243 108 112 10.1038/nature07829 19295514
21. Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Euskirchen GM, Rozowsky JS, Wei CL, Lee WH, Zhang ZD, Hartman S, Emanuelsson O, Stolc V, Weissman S, Gerstein MB, et al. Genome research 2007 17 6 898 909 10.1101/gr.5583007 17568005 (Pubitemid 46919724)
22. Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays. Sabo PJ, Kuehn MS, Thurman R, Johnson BE, Johnson EM, Cao H, Yu M, Rosenzweig E, Goldy J, Haydock A, et al. Nature methods 2006 3 7 511 518 10.1038/nmeth890 16791208 (Pubitemid 43941768)
23. Enhancers: the abundance and function of regulatory sequences beyond promoters. Bulger M, Groudine M, Developmental biology 2010 339 2 250 257 10.1016/j.ydbio.2009.11.035 20025863
24. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. Nature genetics 2007 39 3 311 318 10.1038/ng1966 17277777 (Pubitemid 46328487)
25. Transcription of the S Gene in Transgenic Mice Is Associated with Hypomethylation at Specific Sites and with Dnase I Sensitivity. Pourcel C, Tiollais P, Farza H, Journal of Virology 1990 64 2 931 935 2296089 (Pubitemid 20032715)
26. The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated. Kelley DE, Pollok BA, Atchison ML, Perry RP, Molecular and cellular biology 1988 8 2 930 937 3127693 (Pubitemid 18044890)
27. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Serandour AA, Avner S, Percevault F, Demay F, Bizot M, Lucchetti-Miganeh C, Barloy-Hubler F, Brown M, Lupien M, Metivier R, et al. Genome research 2011 21 4 555 565 10.1101/gr.111534.110 21233399
28. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, et al. Clin Cancer Res 2005 11 16 5793 5801 10.1158/1078-0432.CCR-04-2545 16115918 (Pubitemid 41170305)
29. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Ramaiah SK, Rittling S, Toxicol Sci 2008 103 1 4 13 17890765 (Pubitemid 351524472)
30. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, Hagood JS, American journal of respiratory cell and molecular biology 2008 39 5 610 618 10.1165/rcmb.2007-0322OC 18556592
31. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Wang Y, Fan PS, Kahaleh B, Arthritis and rheumatism 2006 54 7 2271 2279 10.1002/art.21948 16802366 (Pubitemid 44051084)
32. Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice. Lorena D, Darby IA, Gadeau AP, Leen LL, Rittling S, Porto LC, Rosenbaum J, Desmouliere A, Journal of hepatology 2006 44 2 383 390 10.1016/j.jhep.2005.07.024 16221502 (Pubitemid 43069221)
33. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF, American journal of physiology 2004 287 1 264 273 15044174
34. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Kawashima R, Mochida S, Matsui A, YouLuTu ZY, Ishikawa K, Toshima K, Yamanobe F, Inao M, Ikeda H, Ohno A, et al. Biochemical and biophysical research communications 1999 256 3 527 531 10.1006/bbrc.1999.0372 10080931 (Pubitemid 29301139)
35. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury. Ramaiah SK, Rittling S, Expert opinion on drug metabolism & toxicology 2007 3 4 519 526 10.1517/17425255.3.4.519 22313151 (Pubitemid 351324961)
36. Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation. Ariztia EV, Subbarao V, Solt DB, Rademaker AW, Iyer AP, Oltvai ZN, Experimental cell research 2003 288 2 257 267 10.1016/S0014-4827(03)00118-6 12915117 (Pubitemid 36959943)
37. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation. Eden Amir, Gaudet François, Waghmare Alpana, Jaenisch Rudlf, Science 2003 300 18
38. DNA methylation in hepatocellular carcinoma. Tischoff Iris, Tannpfel Andrea, World Journal of Gastroenterology 2008 14 11 1741 1748 10.3748/wjg.14.1741 18350605 (Pubitemid 351493380)
39. Induction of Tumors in Mice by Genomic Hypomethylation. Gaudet François, J Graeme Hodgson, Eden Amir, Laurie Jackson-Grusby, Dausman Jessica, Joe Gray W, Leonhardt Heinrich, Jaenisch Rudolf, Science 2003 300 18
40. Reactivating the expression of methylation silenced genes in human cancer. Adam Karpf R, David Jones A, Oncogene 2002 21 5496 5503 10.1038/sj.onc.1205602 12154410 (Pubitemid 34983484)